«1234567»Seite
11 Artikel mit Literatur, Seite 4 von 11

MEDIZIN: Originalarbeit

Blindheit und Sehbehinderung in Deutschland: Leichter Rückgang der Prävalenz

Blindness and visual impairment in Germany—a slight fall in prevalence
Dtsch Arztebl Int 2012; 109(27-28): 484-9; DOI: 10.3238/arztebl.2012.0484

Finger, Robert P.; Bertram, Bernd; Wolfram, Christian; Holz, Frank G.

1. Finger RP, Fimmers R, Holz FG, Scholl HP: Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol 2011; 95: 1061–7. CrossRef MEDLINE
2. Finger RP: Blindheit in Deutschland: Dimensionen und Perspektiven. Ophthalmologe 2007; 104: 839–44. CrossRef MEDLINE
3. Knauer C, Pfeiffer N: Erblindung in Deutschland – heute und 2030. Ophthalmologe 2006; 103: 735–41. CrossRef MEDLINE
4. Bunce C, Wormald R: Causes of blind certifications in England and Wales: April 1999 – March 2000. Eye 2008; 22: 905–11. CrossRef MEDLINE
5. Farber MD: National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness. Ophthalmic Epidemiol 2003; 10: 267–77. CrossRef MEDLINE
6. Finger RP, Fimmers R, Holz FG, Scholl HP: Incidence of blindness and severe visual impairment in Germany – projections for 2030. Invest Ophthalmol Vis Sci 2011; 52: 4381–9. CrossRef MEDLINE
7. Foran S, Wang JJ, Rochtchina E, Mitchell P: Projected number of Australians with visual impairment in 2000 and 2030. Clin Experiment Ophthalmol 2000; 28: 143–5. CrossRef MEDLINE
8. Abou-Gareeb I, Lewallen S, Bassett K, Courtright P: Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthalmic epidemiology 2001; 8: 39–56. CrossRef MEDLINE
9. Bertram B, Hammers H: Die Prävalenz der Erblindungen wegen diabetischer Retinopathie stiegt weiter. Z prakt Augenheilkd 1997; 18: 181–4.
10. Newcombe RG: Two-sided confidence intervals for the single proportion: Comparison of seven methods. Statistics in Medicine 1998; 17: 857–72. CrossRef MEDLINE
11. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT: Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998; 116: 653–8. MEDLINE
12. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, et al.: High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182–9. MEDLINE
13. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–53. CrossRef MEDLINE
14. Burr J, Azuara-Blanco A, Avenell A: Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev 2005 (2): CD004399. MEDLINE
15. Bartz-Schmidt U, Szurman P, Wong D, Kirchhof B: Neue Entwicklungen in der chirurgischen Therapie der rheumatogenen Ablatio retinae. Ophthalmologe 2008; 105: 27–36. CrossRef MEDLINE
16. Wolfram C, Pfeiffer N: Blindness and low vision in Germany 1993–2009. Ophthalmic epidemiology 2012; 19: 3–7. CrossRef MEDLINE
17. Klein R, Chou CF, Klein BE, Zhang X, Meuer SM, Saaddine JB: Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011; 129: 75–80. CrossRef MEDLINE
18. Huang GH, Klein R, Klein BE, Tomany SC: Birth cohort effect on prevalence of age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 2003; 157: 721–9. CrossRef MEDLINE
19. Klein R, Knudtson MD, Lee KE, Gangnon RE, Klein BE: Age-period-cohort effect on the incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2008; 115: 1460–7. CrossRef MEDLINE PubMed Central
20. Bloch SB, Larsen M, Munch IC: Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010. American Journal of Ophthalmology 2012; 153: 209–13. CrossRef MEDLINE
21. Skaat A, Chetrit A, Belkin M, Kinori M, Kalter-Leibovici O: Time trends in the incidence and causes of blindness in Israel. American Journal of Ophthalmology 2012; 153: 214–21. CrossRef MEDLINE
22. Porz G, Scholl HP, Holz FG, Finger RP: Methoden zur Ermittlung persönlicher Krankheitskosten am Beispiel retinaler Erkrankungen. Ophthalmologe 2010; 107: 216–20. CrossRef MEDLINE
«1234567»Seite
11 Artikel mit Literatur, Seite 4 von 11

Login

E-Mail

Passwort


Passwort vergessen?

Registrieren

Eingeloggt als

Suchen in